Evidence map›Paper›PMID 25425683›Full record

Trial reportHaematologica2015

Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.

Anna M Aalbers, Marry M van den Heuvel-Eibrink, Irith Baumann, Michael Dworzak, Henrik Hasle, Franco Locatelli, Barbara De Moerloose, Markus Schmugge, Ester Mejstrikova, Michaela Nováková and 8 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 8 countries.

Anna M AalbersDepartment of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Pediatric Oncology/Hematology, Sophia Children's Hospital - Erasmus University Medical Center, Rotterdam, The Netherlands.
Marry M van den Heuvel-EibrinkDepartment of Pediatric Oncology/Hematology, Sophia Children's Hospital - Erasmus University Medical Center, Rotterdam, The Netherlands.
Irith BaumannDepartment of Pathology, Clinical Centre South West, Böblingen Clinics, Germany.
Michael DworzakSt. Anna Children's Hospital and Children's Cancer Research Institute, Department of Pediatrics, Medical University of Vienna, Austria.
Henrik HasleDepartment of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark.
Franco LocatelliDepartment of Pediatric Hematology-Oncology, IRCCS Ospedale Bambino Gesù, Rome, University of Pavia, Italy.
Barbara De MoerlooseDepartment of Pediatric Hematology/Oncology, Ghent University Hospital, Ghent, Belgium.
Markus SchmuggeDepartment of Hematology, University Children's Hospital, Zurich, Switzerland.
Ester MejstrikovaDepartment of Pediatric Hematology/Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
Michaela NovákováDepartment of Pediatric Hematology/Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
Marco ZeccaPediatric Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
C Michel ZwaanDepartment of Pediatric Oncology/Hematology, Sophia Children's Hospital - Erasmus University Medical Center, Rotterdam, The Netherlands.
Jeroen G Te MarveldeDepartment of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Anton W LangerakDepartment of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Jacques J M van DongenDepartment of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
Rob PietersDepartment of Pediatric Oncology/Hematology, Sophia Children's Hospital - Erasmus University Medical Center, Rotterdam, The Netherlands.
Charlotte M NiemeyerDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Germany.
Vincent H J van der VeldenDepartment of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands v.h.j.vandervelden@erasmusmc.nl.
Erasmus MC · NLCharles University · CZAarhus University Hospital · DKGhent University Hospital · BEIstituti di Ricovero e Cura a Carattere Scientifico · ITMedical University of Vienna · ATUniversity Children's Hospital Zurich · CHUniversity of Freiburg · DEUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Refractory cytopenia of childhood is the most common type of childhood myelodysplastic syndrome. Because the majority of children with refractory cytopenia have a normal karyotype and a hypocellular bone marrow, differentiating refractory cytopenia from the immune-mediated bone marrow failure syndrome (very) severe aplastic anemia can be challenging. Flow cytometric immunophenotyping of bone marrow has been shown to be a valuable diagnostic tool in differentiating myelodysplastic syndrome from non-clonal cytopenias in adults. Here, we performed the first comprehensive flow cytometric analysis of immature myeloid, lymphoid cells and erythroid cells, and granulocytes, monocytes, and lymphoid cells in bone marrow obtained from a large prospective cohort of 81 children with refractory cytopenia. Children with refractory cyotopenia had a strongly reduced myeloid compartment, but not as severe as children with aplastic anemia. Furthermore, the number of flow cytometric abnormalities was significantly higher in children with refractory cytopenia than in healthy controls and in children with aplastic anemia, but lower than in advanced myelodysplastic syndrome. We conclude that flow cytometric immunophenotyping could be a relevant addition to histopathology in the diagnosis of refractory cytopenia of childhood. (The multi-center studies EWOG-MDS RC06 and EWOG-MDS 2006 are registered at clinicaltrials.gov identifiers 00499070 and 00662090, respectively).

Indexed as

ImmunophenotypingAdolescentAnemia, AplasticAntigens, CDBone MarrowChildChild, PreschoolDiagnosis, DifferentialErythroid CellsFemaleFlow CytometryGranulocytesHumansInfantLymphocytesMonocytesAntigens, CD

Identifiers

PMID25425683
PMCPMC4349269
OpenAlexW2074423820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.